Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
In other words, a non-painful stimulus – like when you rub your shin after walking into a table – can overtake slower pain ...